Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Julie Smith > Profile

Julie Smith

Affiliations

  • at Stoke Therapeutics Inc. (STOK), 2025-06-05
  • Director at Exelixis Inc. (EXEL), 2025-05-30
  • Director at Audentes Therapeutics Inc. (BOLD), 2020-01-15
  • President And Ceo at Raptor Pharmaceutical Corp (RPTP), 2016-10-26
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EXEL $37.62 19,294 $725,840.28 10,778 2025-02-28 Filing
EXEL $38.13 54,514 $2,078,618.82 10,778 2025-02-27 Filing
EXEL $21.12 27,280 $576,153.60 5,445 2024-05-21 Filing